CL2020000362A1 - Nuevos compuestos. - Google Patents

Nuevos compuestos.

Info

Publication number
CL2020000362A1
CL2020000362A1 CL2020000362A CL2020000362A CL2020000362A1 CL 2020000362 A1 CL2020000362 A1 CL 2020000362A1 CL 2020000362 A CL2020000362 A CL 2020000362A CL 2020000362 A CL2020000362 A CL 2020000362A CL 2020000362 A1 CL2020000362 A1 CL 2020000362A1
Authority
CL
Chile
Prior art keywords
new compounds
treatment
compounds
mycobacteria
tuberculosis
Prior art date
Application number
CL2020000362A
Other languages
English (en)
Inventor
De Francisco Esther Porras
Blanco Modesto Jesús Remuiñan
Marilyne Bourotte
Benoit Deprez
Nicolas Willand
Original Assignee
Glaxosmithkline Ip Dev Ltd
BioVersys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59713957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2020000362(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Ip Dev Ltd, BioVersys AG filed Critical Glaxosmithkline Ip Dev Ltd
Publication of CL2020000362A1 publication Critical patent/CL2020000362A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCIÓN SE REFIERE A COMPUESTOS DE FÓRMULA (I) Y SU USO EN TERAPIA, POR EJEMPLO EN EL TRATAMIENTO DE INFECCIONES MICOBACTERIANAS O EN EL TRATAMIENTO DE ENFERMEDADES CAUSADAS POR MICOBACTERIA, TALES COMO LA TUBERCULOSIS.
CL2020000362A 2017-08-16 2020-02-12 Nuevos compuestos. CL2020000362A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382569 2017-08-16

Publications (1)

Publication Number Publication Date
CL2020000362A1 true CL2020000362A1 (es) 2020-07-10

Family

ID=59713957

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020000362A CL2020000362A1 (es) 2017-08-16 2020-02-12 Nuevos compuestos.

Country Status (25)

Country Link
US (1) US11254689B2 (es)
EP (1) EP3668879B1 (es)
JP (1) JP7171726B2 (es)
KR (1) KR102657360B1 (es)
CN (1) CN110997680B (es)
AU (1) AU2018317804B2 (es)
BR (1) BR112020003192A2 (es)
CA (1) CA3072838A1 (es)
CL (1) CL2020000362A1 (es)
CO (1) CO2020001506A2 (es)
CY (1) CY1124851T1 (es)
DK (1) DK3668879T3 (es)
ES (1) ES2899365T3 (es)
HR (1) HRP20211895T1 (es)
HU (1) HUE056928T2 (es)
IL (1) IL272562B2 (es)
LT (1) LT3668879T (es)
MX (1) MX2020001808A (es)
PL (1) PL3668879T3 (es)
PT (1) PT3668879T (es)
RS (1) RS62708B1 (es)
SG (1) SG11202000988RA (es)
SI (1) SI3668879T1 (es)
WO (1) WO2019034700A1 (es)
ZA (1) ZA202000585B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111184718A (zh) * 2018-11-15 2020-05-22 鲁南制药集团股份有限公司 法罗培南在制备治疗初治病原学阳性肺结核药物中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
DE102005044813A1 (de) * 2005-05-19 2007-10-04 Grünenthal GmbH Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
FR3000064A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
FR3000065A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
KR20150034498A (ko) * 2013-09-26 2015-04-03 주식회사 엘지화학 벤팅 커버를 구비하는 배터리 셀 및 이를 포함하는 이차전지

Also Published As

Publication number Publication date
DK3668879T3 (da) 2021-12-06
CA3072838A1 (en) 2019-02-21
CO2020001506A2 (es) 2020-05-29
IL272562B1 (en) 2023-04-01
RU2020109677A (ru) 2021-09-16
US11254689B2 (en) 2022-02-22
EP3668879B1 (en) 2021-09-29
HRP20211895T1 (hr) 2022-08-19
RS62708B1 (sr) 2022-01-31
AU2018317804A1 (en) 2020-02-20
ZA202000585B (en) 2021-07-28
ES2899365T3 (es) 2022-03-11
LT3668879T (lt) 2022-03-25
PL3668879T3 (pl) 2022-02-21
EP3668879A1 (en) 2020-06-24
AU2018317804B2 (en) 2021-04-22
SG11202000988RA (en) 2020-03-30
CN110997680B (zh) 2022-10-21
HUE056928T2 (hu) 2022-03-28
IL272562A (en) 2020-03-31
CN110997680A (zh) 2020-04-10
US20210032268A1 (en) 2021-02-04
BR112020003192A2 (pt) 2020-09-15
JP7171726B2 (ja) 2022-11-15
PT3668879T (pt) 2021-12-02
SI3668879T1 (sl) 2022-04-29
RU2020109677A3 (es) 2021-09-28
IL272562B2 (en) 2023-08-01
JP2020531575A (ja) 2020-11-05
MX2020001808A (es) 2022-07-19
KR102657360B1 (ko) 2024-04-16
CY1124851T1 (el) 2022-11-25
WO2019034700A1 (en) 2019-02-21
KR20200041344A (ko) 2020-04-21

Similar Documents

Publication Publication Date Title
CL2017003404A1 (es) Compuestos antibacterianos
CO2019000386A2 (es) Compuestos heterocíclicos como inmunomoduladores
CL2018003681A1 (es) Derivados de ácido borónico y usos terapéuticos de los mismos
CO2017011851A2 (es) Compuestos novedosos
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
UY37124A (es) Nuevos compuestos de 6,7-dihidro-5h-benzo[7]anuleno sustituidos, procesos para su preparación y usos terapéuticos de los mismos
UY37480A (es) Nuevos derivados de quinolina
DOP2016000144A (es) Moduladores de tetrahidropiridopirazinas de gpr6
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
CL2019001565A1 (es) Composición farmacéutica para prevenir o tratar el cáncer, comprendiendo el polímorfo cristalino del hexoxido tetraarsénico.
CR20160564A (es) Dinucleótidos cíclicos como moduladores de sting
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
EA201990044A1 (ru) Гетероциклические соединения в качестве антибактериальных средств
CL2018001569A1 (es) Compuestos heteroaromáticos como inhibidores de btk
GT201600269A (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
CL2016002091A1 (es) Compuesto de triazina y su uso para fines medicinales
UY36737A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
UY35274A (es) Compuestos y métodos para tratar infecciones bacterianas
PL410665A1 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
GT201500235A (es) Estra -1,3,5 (10) , 16- tetraeno -3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1c3)
PH12016501988A1 (en) Antibacterial compounds
UY36070A (es) Triterpenoides con actividad inhibidora de la maduración de hiv
UY34615A (es) Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias.
EA201891644A1 (ru) Антибактериальные соединения и их применение
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo